Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.00
Bid: 358.00
Ask: 379.00
Change: 0.00 (0.00%)
Spread: 21.00 (5.866%)
Open: 362.00
High: 0.00
Low: 0.00
Prev. Close: 362.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

26 Oct 2010 07:00

RNS Number : 9763U
Microgen PLC
26 October 2010
 



microgen

www.microgen.com

 

26 October 2010

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') announces its Interim Management Statement covering the period from 1 July 2010 to the date of this announcement. Microgen announced its interim results for the six months ending 30 June 2010 on 22 July 2010.

 

The Group's financial results for the three months ended 30 September 2010 are in line with the Board's expectations. A £6.2 million tender offer was completed in September and there have been no other significant changes in the financial position or trading of Microgen since that date. The Group's balance sheet remains strong and following the tender offer and £0.8 million interim dividend, Microgen had cash of £19.0 million (30 June 2010: £25.0 million) and net funds of £17.1 million (30 June 2010: £23.0 million) as at 30 September 2010.

 

Since 30 June 2010 the Microgen Aptitude Solutions Division has entered into a number of licence agreements and extensions with new and existing clients. The Microgen Aptitude Solutions Division also released significant new functional and performance modules in September for its flagship Business Process Platform, Microgen Aptitude. The Financial Systems Division continues to trade in line with our expectations, benefiting from its high levels of recurring revenue and strong cash flows.

 

While the Board remains cautious and prudent, Microgen remains on track to meet its expectations for the year.

 

 

Contacts

Martyn Ratcliffe, Chairman 01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, Financial Dynamics 020-7831-3113

Haya Herbert-Burns, Financial Dynamics

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMABFTMBBTBAM
Date   Source Headline
3rd Jul 20207:00 amRNSTrading Update and Notice of Results
11th Jun 20204:41 pmRNSSecond Price Monitoring Extn
11th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20204:35 pmRNSPrice Monitoring Extension
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
2nd Jun 20204:35 pmRNSPrice Monitoring Extension
1st May 20207:00 amRNSTotal Voting Rights
29th Apr 202012:16 pmRNSDisclosure of Rights attached to Ordinary Shares
28th Apr 202012:45 pmRNSResult of AGM
21st Apr 20207:00 amRNSCOVID-19 Update and AGM Arrangements
8th Apr 20205:02 pmRNSDirector/PDMR Shareholding
8th Apr 20204:59 pmRNSDirector/PDMR Shareholding
27th Mar 202012:38 pmRNSBlock listing Interim Review
18th Mar 20205:00 pmRNSAnnual Report and Notice of AGM
16th Mar 20201:52 pmRNSBlock Listing Application
13th Mar 20205:11 pmRNSDirector/PDMR Shareholding
11th Mar 20207:00 amRNSAudited Preliminary Results
13th Feb 20205:26 pmRNSHolding(s) in Company
3rd Feb 20201:54 pmRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSTrading Update, Board Changes & Notice of Results
15th Jan 202012:01 pmRNSHolding(s) in Company
3rd Jan 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jan 202012:02 pmRNSPrice Monitoring Extension
3rd Jan 20207:00 amRNSTotal Voting Rights
3rd Dec 20192:52 pmRNSHolding(s) in Company
2nd Dec 201910:28 amRNSTotal Voting Rights
12th Nov 20191:48 pmRNSDirector/PDMR Shareholding
11th Nov 20197:00 amRNSHolding(s) in Company
1st Nov 20197:00 amRNSTotal Voting Rights
29th Oct 20197:00 amRNSAward of Options
23rd Oct 20193:19 pmRNSHolding(s) in Company
4th Oct 20197:00 amRNSChange of Auditor and Partner Programme
30th Sep 20196:03 pmRNSHolding(s) in Company
30th Sep 20197:21 amRNSHolding(s) in Company
27th Sep 20199:35 amRNSHolding(s) in Company
26th Sep 20192:25 pmRNSBlock Listing Interim Review
26th Sep 20198:30 amRNSAcceptance of the B Share Purchase Offer
25th Sep 20198:00 amRNSPurchase Offer for B Shares
24th Sep 20197:00 amRNSIssue of B Shares and Share Consolidation
23rd Sep 20191:50 pmRNSReturn of Value and Result of GM
11th Sep 20196:03 pmRNSHolding(s) in Company
9th Sep 20192:27 pmRNSHolding(s) in Company
9th Sep 20192:13 pmRNSHolding(s) in Company
3rd Sep 20197:00 amRNSPublication of Circular and Notice of GM
2nd Sep 20194:16 pmRNSCorrection: Issue of Consideration Shares
2nd Sep 20191:37 pmRNSConfirmation of Directorate Change
2nd Sep 20197:00 amRNSIssue of Consideration Shares
29th Aug 20191:23 pmRNSHolding(s) in Company
27th Aug 201910:07 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.